These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 23774644

  • 1. Genetics: ZBTB7A suppresses castration-resistant prostate cancer.
    Razzak M.
    Nat Rev Clin Oncol; 2013 Aug; 10(8):427. PubMed ID: 23774644
    [No Abstract] [Full Text] [Related]

  • 2. Prostate cancer: of mice and men--a co-clinical approach to CRPC.
    Payton S.
    Nat Rev Urol; 2013 Aug; 10(8):429. PubMed ID: 23774961
    [No Abstract] [Full Text] [Related]

  • 3. Leveraging the species barrier to advance cancer therapy.
    Zhao S, Nelson PS.
    Nat Genet; 2013 Jul; 45(7):718-20. PubMed ID: 23800864
    [Abstract] [Full Text] [Related]

  • 4. Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion.
    Wang G, Lunardi A, Zhang J, Chen Z, Ala U, Webster KA, Tay Y, Gonzalez-Billalabeitia E, Egia A, Shaffer DR, Carver B, Liu XS, Taulli R, Kuo WP, Nardella C, Signoretti S, Cordon-Cardo C, Gerald WL, Pandolfi PP.
    Nat Genet; 2013 Jul; 45(7):739-746. PubMed ID: 23727861
    [Abstract] [Full Text] [Related]

  • 5. Castration-resistant prostate cancer: a strategy to enhance response to androgen deprivation.
    Stanevsky Y, Tsivian A, Tsivian M.
    Asian J Androl; 2013 Nov; 15(6):709-10. PubMed ID: 23893155
    [Abstract] [Full Text] [Related]

  • 6. A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer.
    Lunardi A, Ala U, Epping MT, Salmena L, Clohessy JG, Webster KA, Wang G, Mazzucchelli R, Bianconi M, Stack EC, Lis R, Patnaik A, Cantley LC, Bubley G, Cordon-Cardo C, Gerald WL, Montironi R, Signoretti S, Loda M, Nardella C, Pandolfi PP.
    Nat Genet; 2013 Jul; 45(7):747-55. PubMed ID: 23727860
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Stimulation of cellular senescent processes, including secretory phenotypes and anti-oxidant responses, after androgen deprivation therapy in human prostate cancer.
    Kawata H, Kamiakito T, Nakaya T, Komatsubara M, Komatsu K, Morita T, Nagao Y, Tanaka A.
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):219-227. PubMed ID: 27329245
    [Abstract] [Full Text] [Related]

  • 9. Abiraterone and novel antiandrogens: overcoming castration resistance in prostate cancer.
    Ferraldeschi R, Pezaro C, Karavasilis V, de Bono J.
    Annu Rev Med; 2013 Jan; 64():1-13. PubMed ID: 23020876
    [Abstract] [Full Text] [Related]

  • 10. [Mechanism on androgen-independent progression of prostate cancer].
    Shimazaki J, Akakura K, Furuya Y, Ito H.
    Nihon Rinsho; 1997 May; 55(5):1143-8. PubMed ID: 9155166
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cytology of metastatic prostate cancer following orchiectomy and antiandrogen therapy: a diagnostic challenge.
    Rapkiewicz A, Gorokhovsky R, Farcon E, Das K.
    Diagn Cytopathol; 2008 Jul; 36(7):499-502. PubMed ID: 18528888
    [Abstract] [Full Text] [Related]

  • 14. Intra-prostatic androgen levels during various androgen-blockade regimens.
    Nishiyama T.
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):229-41. PubMed ID: 18471782
    [Abstract] [Full Text] [Related]

  • 15. [Qualitative and quantitative hormonal regulation in castration-resistant prostate cancer].
    Murez T, Basset V, Audenet F, Lebret T, Branchereau J.
    Prog Urol; 2013 Oct; 23 Suppl 1():S1-8. PubMed ID: 24314734
    [Abstract] [Full Text] [Related]

  • 16. Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells.
    Burton DG, Giribaldi MG, Munoz A, Halvorsen K, Patel A, Jorda M, Perez-Stable C, Rai P.
    PLoS One; 2013 Oct; 8(6):e68003. PubMed ID: 23840802
    [Abstract] [Full Text] [Related]

  • 17. Hormonal therapy of prostate cancer.
    Labrie F.
    Prog Brain Res; 2010 Oct; 182():321-41. PubMed ID: 20541672
    [Abstract] [Full Text] [Related]

  • 18. [Combined treatment of metastatic hormone-resistant prostate cancer].
    Kaprin AD, Gafanov RA, Al'bitskiĭ IA, Fastovets SV.
    Vopr Onkol; 2009 Oct; 55(4):477-9. PubMed ID: 19947375
    [No Abstract] [Full Text] [Related]

  • 19. [Prostatic cancer and its androgen-dependency].
    Shimazaki J, Isaka S, Akimoto S, Sumiya H, Ichikawa T, Akakura K, Furuya Y.
    Gan No Rinsho; 1989 May; Spec No():268-76. PubMed ID: 2513430
    [No Abstract] [Full Text] [Related]

  • 20. Androgen action in the prostate gland.
    Yadav N, Heemers HV.
    Minerva Urol Nefrol; 2012 Mar; 64(1):35-49. PubMed ID: 22402316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.